Sokhom Pin, Ph.D.
Vice President, Head of Biology | Superluminal Medicines Inc. | Boston, MA
Professional Overview
Sokhom Pin, Ph.D., is an accomplished biopharmaceutical executive with over 20 years of experience leading high-impact scientific research and development initiatives. As the Vice President and Head of Biology at Superluminal Medicines Inc., he oversees the company's preclinical and early-stage clinical research efforts, driving the development of innovative therapeutic solutions.
Experience Summary
Current Role
As the Vice President and Head of Biology at Superluminal Medicines Inc., Dr. Pin is responsible for leading the company's biology and pharmacology research. He directs a team of cross-functional scientists in the design, execution, and interpretation of in vitro and in vivo studies to support the advancement of Superluminal's drug pipeline. Under his leadership, the biology team has established robust platforms for target identification, lead optimization, and candidate selection, contributing to the company's progress in bringing promising therapeutics to the clinic.
Career Progression
Prior to joining Superluminal, Dr. Pin held senior leadership roles in the biopharmaceutical industry, including serving as the Senior Director and Head of In Vitro Pharmacology at AbbVie and the Senior Director and Head of In Vitro Pharmacology-Neuroscience at Cerevel Therapeutics. In these positions, he led the development of innovative in vitro assays and screening platforms to support drug discovery programs across various therapeutic areas, with a particular focus on neuroscience. Earlier in his career, he held positions at Alkermes, Novartis, and DuPont, where he contributed to the advancement of novel drug candidates and the establishment of robust pharmacology capabilities.
Academic Background
Dr. Pin holds a Ph.D. in Pharmacology from Johns Hopkins University, where he specialized in the study of neurotransmitter systems and their modulation in the context of neurological and psychiatric disorders. His doctoral research focused on the development of novel therapeutic approaches for the treatment of depression and anxiety disorders.
Areas of Expertise
- Preclinical drug discovery and development
- In vitro pharmacology and assay development
- Translational neuroscience research
- Target identification and lead optimization
- Cross-functional team leadership and collaboration
- Strategic planning and portfolio management
Professional Impact
Throughout his career, Dr. Pin has played a pivotal role in advancing multiple drug candidates through the preclinical and early-clinical stages. His contributions have been instrumental in the successful progression of several programs, including the identification and validation of novel targets, the development of robust assays and screening platforms, and the optimization of lead compounds. Dr. Pin's expertise and leadership have had a significant impact on the biopharmaceutical industry, as evidenced by his numerous scientific publications and presentations at industry conferences.
Conclusion
With his extensive experience, scientific expertise, and proven track record of leadership, Dr. Sokhom Pin is well-positioned to drive Superluminal Medicines Inc.'s biology and pharmacology research efforts, contributing to the company's mission of developing transformative therapies for patients in need.
